title: [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity].
abstract: Data were collected from organised Italian cervical screening programmes on: a) the correlation between colposcopic findings (according to the 1990 international classification) and histology, and (b) the treatment/management of screen-detected histologically-confirmed cervical intraepithelial neoplasia (CIN). Data routinely registered by organised programmes were obtained as aggregated tables. Of the 26,320 reported colposcopies, 39.6% were classified as normal and 11.2% as unsatisfactory. CIN2 or more severe histology was detected in 65.3% of colposcopies classified as grade 2 or higher. Of all colposcopies, the outcome of which was CIN2 or more severe histology, 42.7% were classified as grade 2 or higher. Of the 5,695 women with CIN1, 78.9% were recommended to have follow-up only. However, 1.4% of them had cold-knife conisation and 4.5% were treated by diathermocoagulation. Of the 3,841 women with CIN2 or CIN3, 6.4% had not yet been treated when data were collected, and no data rewere available for a further 12.7%. Excision by radio-frequency device was the most common treatment among these women (64.1% of those with known treatment). However, 0.7% of all CIN2 and 1.7% of all CIN3 had hysterectomy. Among the 151 women with invasive carcinoma, 10.6% plausibly with microinvasive disease, only one treatment LLETZ is reported.
authors.affiliation: CPO Piemonte, Torino. guglielmo.ronco@cpo.it
authors.forename: Renzo
authors.initials: R
authors.lastname: Volante
authors.forename: Pamela
authors.initials: P
authors.lastname: Giubilato
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Ronco
mesh_terms: D000328:Adult; D002277:Carcinoma / Q000473:pathology / Q000601:surgery; D003127:Colposcopy / Q000592:standards*; D019092:Conization / Q000706:statistics & numerical data; D055088:Early Detection of Cancer / Q000379:methods / Q000592:standards*; D004564:Electrocoagulation / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data; D007558:Italy / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D008875:Middle Aged; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control / Q000601:surgery; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control / Q000601:surgery